Catalyst Pharmaceuticals
Major Drugs - Coral Gables, FL, US
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals Senior Management
Catalyst Pharmaceuticals Details
Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, first- or best-in-class medicines for other rare diseases. Catalyst's New Drug Application for FIRDAPSE® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
Catalyst Pharmaceuticals Technologies
Email Providers
Outlook
Marketing Automation
Pardot
Customer Relationship Management
Salesforce
Domain Name Services
Cloudflare DNS
Email Delivery
Mailchimp Mandrill